SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization of $318K in Q1 FY2026

Q1 FY2026 depreciation & amortization was $318K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$318K+46.7% QoQ
Last fiscal yearDec 2025
$612K— YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
612K USD
Year-over-year change
—

Depreciation & Amortization vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Depreciation & Amortization for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$1.84B USD+41.7%+5.9%16.9%
BLCOBausch + Lomb CorporationLTM Jun 2026$411M USD-4.2%+3.6%7.7%
GKOSGlaukos CorporationLTM Jun 2026$46.44M USD+19.7%+5.6%7.6%
STAASTAAR Surgical CompanyLTM Apr 2026$8.6M USD+7.6%+24.6%3.0%
OCULOcular Therapeutix, Inc.LTM Mar 2026$4.63M USD+20.3%+27.0%8.9%
RXSTRxSight, Inc.LTM Mar 2026$3.32M USD+1.7%—2.6%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$2.45M USD+41.2%-1.9%32.1%
SGPSpyGlass Pharma, Inc. Common StockFY2025$612K USD———
SGHTSight Sciences, Inc.LTM Mar 2026$441K USD-24.4%-27.0%0.6%
OCSOculis Holding AGLTM Mar 2026CHF 422.43K CHF-7.4%+20.4%83.8%
Peer median (excluding SGP) —+7.6%+5.8%7.7%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.